Abstract

This study presents the first ultra-high performance supercritical fluid chromatography–diode array detector (UHPSFC–DAD) assay for simultaneous quantitation of secoiridoids, iridoids, xanthones, and xanthone glycosides in Gentiana lutea L. Separation was reached within 12 min on an Acquity UPC2 BEH 2-EP column using CO2 and methanol with 5.5% water as mobile phases. Method validation for nine selected marker compounds (gentisin, isogentisin, swertiamarin, sweroside, gentiopicroside, loganic acid, amarogentin, gentioside, and its isomer) confirmed the assay’s sensitivity, linearity, precision, and accuracy. The practical applicability was proven by the analysis of 13 root specimens and 10 commercial liquid preparations (seven liqueurs and three clear spirits). In all root batches, the secoiridoid gentiopicroside dominated (2.1–5.6%) clearly over all other metabolites. In the liqueurs, the metabolite content and distribution were extremely variable: while gentiopicroside was the main compound in four liqueurs, sweroside dominated in one preparation and loganic acid in two others. In contrast, measurable amounts of the metabolites were not detected in any of the examined clear spirits.
Keywords: yellow gentian, supercritical fluid chromatography, liqueurs, secoiridoids, natural product analysis
1. Introduction
Herbal preparations, especially those with bitter constituents, have taken on a firmly established role in the therapy of functional gastrointestinal diseases.1 Bitter constituents with their large chemical diversity belong to a waste number of different chemical compound classes and are distributed in many plant families.2 A widely used and well-studied plant in this context is yellow gentian (Gentiana lutea L., Gentianaceae). The medicinally used part of the plant is the root, which is listed in the European pharmacopeia (Ph. Eur.) under the monograph “Gentianae Radix”. It contains up to 8% bitter-tasting secoiridoid glycosides, including gentiopicroside as the main constituent, as well as amarogentin, swertiamarin, and sweroside.3−6 Due to the extensive use, the committee on herbal medicinal products (HMPC) declared the qualification as traditional herbal medicinal product as fulfilled and defined the indication “for temporary loss of appetite as well as for mild dyspeptic/gastrointestinal disorders” as supported.7 Similar statement is also given by the European Scientific Cooperative on Phytotherapy (ESCOP) who defined “loss of appetite e.g., after illness and dyspeptic complaints” as therapeutic indications.8 Beside the positive effect on the gastrointestinal tract, a variety of other pharmacological activities have been described for gentian root, including antioxidant,9−11 antimicrobial,12 antibacterial,13,14 antifungal,15 hepatoprotective,16 antiatherosclerotic,17 wound-healing,18 immunological,19 and secretolytic20 effects. These various effects are attributed not only to the contained bitter-tasting secoiridoid glycosides but also to further secondary metabolite classes.11,12,18,21−23 The xanthone isogentisin, for example, showed a cell-protecting activity, while its isomer gentisin was only recently identified as inhibitor of vascular smooth muscle cell proliferation.25,26
Beside its usage for medicinal purposes, in alpine regions, the root is also popular for the production of clear spirits and liqueurs. Both, clear spirits and liqueurs, are commercially available and used as appetizers and digestives since centuries. While clear spirits are obtained by the distillation of fermented gentian root mash, liqueurs are prepared by maceration: dried or fresh gentian roots are cut and steeped in spirit for several weeks.27 We wondered whether the substances known to mediate the aforementioned bioactivities can also be found in such preparations. Root samples of Ph. Eur. quality, the starting material for any pharmaceutical preparation but not necessarily for locally produced liqueur or clear spirit formulations, served as comparator samples.
An adequate quality assessment method for gentian root and preparations thereof must address all pharmacologically relevant compounds including bitter-tasting secoiridoids, iridoids, xanthones, and xanthone glycosides. However, even though several different analytical studies dealt with the quality control of G. lutea L., only a few studies published in the past two decades fulfilled this criterion.28−32 In addition, to the best of our knowledge, although gentian spirits and liqueurs are commercially available and widely used, quantitative investigations of these preparations are missing.
The fact that the published methods rely only on conventional HPLC-UV assays with total runtimes of at least 35 min encouraged us to search for a more innovative methodology for the rapid secondary metabolite profile assessment. We did choose ultra-high performance supercritical fluid chromatography (UHPSFC) for our analytical study since this interesting technique has shown big potential for natural product analysis and has never been used for this task before.33−35 Modern UHPSFC approaches are based on the combinatory use of carbon dioxide and organic solvents (so-called modifiers) as mobile phases. These mixtures are combining advantages like low viscosity and high diffusivity of gas chromatography with high dissolving capabilities and densities of liquid chromatography.36 Recent publications have not only demonstrated UHPSFC’s potential as an eco-friendly analytic alternative for highly polar plant constituents but also demonstrated its suitability for the simultaneous determination of compounds with divergent polarity, which makes it a powerful tool in the modern natural product analysis.37−41
2. Materials and Methods
2.1. Chemicals and Reference Compounds
All solvents and reagents (methanol, ethanol, isopropanol, formic acid) used in this study were of HPLC grade and purchased from Merck (Darmstadt, Germany). Carbon dioxide (4.5 grade, purity > 99.995%) was purchased from Messer (Gumpoldskirchen, Austria). Ultrapure water was produced by a Sartorius Arium 611 UV water purification system (Sartorius Stedim Biotech, Göttingen, Germany).
Thirteen samples of G. radix (R-1–R-13) were purchased from various companies in Austria and Germany. Voucher specimens (voucher nos. NGE-GL1–NGE-GL13) of all batches are deposited at the Institute of Pharmacy, University of Innsbruck. Three clear spirit samples (S-1–S-3) and seven traditionally prepared liqueur samples (L-1–L-7) were obtained from local suppliers (Austria and Italy). According to the suppliers, for the production of clear gentian spirits, the dried or fresh roots were fermented, and the obtained mash was distilled. For the liqueur preparation, the whole or cut roots were placed into a bottle, filled up with spirit, and kept under these conditions for at least 4 weeks.
The reference compounds swertiamarin 3, sweroside 4, gentiopicroside 5, loganic acid 6, and amarogentin 7 were obtained from PhytoLab (Vestenbergsreuth, Germany). Gentisin 1, isogentisin 2, gentioside 8, and its isomer 9 were isolated from a methanol extract of G. radix (R-1) following a previously published protocol.26 Identity of the isolated reference compounds was confirmed by the analysis of spectroscopic and spectrometric data (1D- and 2D-NMR, LC-MS) and was in good agreement with the literature.42 Purity was determined by UHPSFC–DAD and was found to exceed 95% in all cases. NMR spectroscopic data and a detailed description of the isolation procedure of compounds 1, 2, 8, and 9 are reported in the Supporting Information.
2.2. Sample Preparation
Gentian root batches (R-1–R-13) were finely pulverized to homogeneity with a coffee mill (3 × 1 min grinding time). The material (200.0 ± 0.1 mg) was weighed into 5.0 mL polyethylene microcentrifuge tubes (Eppendorf, Hamburg, Germany), mixed with 2.0 mL methanol on a Vortex mixer (VWR, Vienna, Austria), and sealed. Extraction was consequently conducted by sonication for 10 min at ambient temperature (Bandelin Sonorex, Berlin, Germany). To avoid temperature elevation, the water in the ultrasonic bath was changed after each extraction step. After the extraction, the samples were centrifuged at 10 600g for 5 min and the supernatant was transferred into a 10 mL volumetric flask. To ensure complete extraction (absolute recovery), the whole procedure was repeated four more times, the supernatants were combined, and the flask was filled up to volume with methanol.
Regarding the liquid preparations, 1.5 mL of each liqueur and clear spirit was evaporated to dryness and redissolved in 0.75 mL of MeOH. Recovery of this step was evaluated by the analogous workup of reference material samples dissolved in 40% EtOH/water (v/v). Due to the high concentration of 5, samples L-3 and L-7 had to be diluted 1:1 (v/v) with methanol before quantitation. All sample solutions were prepared in triplicate, filtered (0.45 μm cellulose acetate membrane, VWR, Vienna, Austria), and stored at 4 °C until analysis.
2.3. UHPSFC–DAD and UHPSFC–MS Conditions
UHPSFC–DAD analysis was conducted on an Acquity UPC2 instrument, equipped with an autosampler, a binary solvent delivery pump, a column oven, a dual-stage active and static automated back-pressure regulator (ABPR), and a diode array detector (Waters, Milford, MA). An Acquity UPC2 BEH 2-EP column (3.0 × 150 mm, 1.7 μm particle size, Waters) was used as the stationary phase, and CO2 (A) and 5.5% water in methanol (B) were used as mobile phases. The gradient for separation was performed as follows: 100% A at 0 min, 85% A at 0.2 min, 85% A at 5.5 min, 83% A at 5.7 min, 79% A at 6.2 min, and 73% A at 10.0 min and held at this composition for 2 min (total runtime: 12 min); then, the column was equilibrated for 5 min under the initial conditions. Flow rate, column temperature, and ABPR were set to 1.10 mL/min, 35 °C, and 1500 psi. The injection volume was 1 μL, and the detection wavelengths were set to 232, 240, 257, and 268 nm.
UHPSFC–MS experiments for peak assignment and peak purity confirmation were performed by coupling the Acquity UPC2 system to a triple quadrupole mass spectrometer (Xevo TQD, Waters). UHPSFC separation conditions were identical to those described above. Methanol fortified with 0.5% formic acid was added as makeup solvent with a flow rate of 0.45 mL/min by a 515 pump and a pump control module (Waters). MS experiments were performed in the negative electrospray ionization (ESI) mode with the following parameters: desolvation temperature 250 °C, desolvation gas flow 200 L/h, capillary voltage 3.50 kV, and cone voltage 20 V. The scan range was set to 200–700 m/z with a scan time of 0.2 s.
2.4. Calibration and Method Validation
Two individual stock solutions of each standard compound (1–9) were prepared by separately weighing and dissolving them in methanol. Out of them, additional calibration levels were prepared by serial dilution. Calibration curves were obtained by plotting the peak areas versus the concentrations of the analytes. Linear regression analysis was used for the calculation of the regression parameters. Limit of detection (LOD) and limit of quantitation (LOQ) estimates were calculated from the regression models (including only the three lowest calibration levels) as 3 (LOD) or 10 times (LOQ) the residual standard deviation of the regression line divided by the slope. The lower LOQ was set to the lowest calibrator level.43 Precision was determined by triplicate analysis of three independently prepared G. radix samples of R-1 (intraday precision) on three consecutive days (interday precision) and is presented as the relative standard deviation (RSD) of the replicate measurements. Accuracy was determined at three different levels (low, medium, and high) by spiking sample R-1 with known amounts of standards 1 and 3–8 prior to sample workup. All samples were prepared in triplicate. To assess sample stability over the validation period, calibrators and samples of the first day were stored at 4 °C and remeasured on the last day. To address stability over the study period, a prealiquoted sample of R-1 was measured daily throughout the measurement campaign. In both cases, the relative deviation from the first measurement value was evaluated.
2.5. Statistics
Microsoft Excel 2016 (Redmond, WA) was used for the calculation of analyte concentrations and data analysis for validation.
3. Results and Discussion
3.1. Sample Preparation for UHPSFC Measurements
Two different sample types, namely, gentian root specimens and liquid beverages thereof, were investigated in this study. In the case of the root samples, the extraction procedure was adopted with slight modifications from a published protocol.28 Five cycles of ultrasound-assisted extraction with methanol as solvent turned out to be necessary for the exhaustive extraction of all relevant compounds, including secoiridoids, as well as iridoids, xanthones, and xanthone glycosides (see Figure 1 for structures). The suitability of the selected sample preparation procedure was proven as follows: a sample was extracted as described in Section 2.2. Then, the remaining root material was extracted once more, and the obtained supernatant was analyzed by UHPSFC. As in this solution, no quantifiable amounts of compounds 1–9 were found, the applied extraction protocol was considered exhaustive and suitable for quantitative investigation.
Figure 1.
Chemical structures of the determined secondary metabolites in G. radix.
Several publications have highlighted the influence of sample solvent composition on peak shape and thus quantitative results in SFC separations.44 Therefore, to ensure a meaningful comparability of the quantitative results of root and beverage samples, clear spirits and liqueurs were not injected directly but evaporated to dryness and subsequently dissolved in methanol. To evaluate the possible analyte loss in the evaporation step, samples of analyte standards were prepared in a matrix mimicking the liqueurs and spirits and processed analogous to the liquid samples. Recoveries were found to be within the range of the validation experiments.
3.2. UHPSFC–DAD and UHPSFC–MS Method Developments
A methanolic gentian root extract and a standard mixture containing nine key metabolites (gentisin (1), isogentisin (2), swertiamarin (3), sweroside (4), gentiopicroside (5), loganic acid (6), amarogentin (7), gentioside (8), and its isomer (9); for structures, see Figure 1) served as samples for method development. The major hurdle in that respect was related to the wide polarity range of the analytes, on one side, and the close structural resemblance of some compounds, on the other side. Therefore, careful evaluation of all relevant separation parameters was necessary.
Supercritical CO2 is a highly lipophilic solvent with a polarity similar to hydrocarbons. Analysis of more polar compounds demands the addition of an organic solvent, the so-called modifier, to the mobile phase.36 Consequently, as first step, the performance of various modifiers (methanol, acetonitrile, isopropanol, and mixtures thereof) on different stationary phases (C-18, fluorophenyl, BEH 2-EP, DIOL, BEH) was evaluated. These experiments revealed that a mixture of CO2 and methanol as mobile phases and an Acquity UPC2 BEH 2-EP column are best suited for the described separation. It became obvious that in the SFC mode one had to face completely different separation challenges as in the HPLC mode. Aberham et al. described the separation of the xanthone aglyca gentisin 1 and isogentisin 2 as the major hurdle during the HPLC method optimization, reached only by changing the mobile phase to a mixture of acetonitrile and n-propanol.28 SFC mode, with its high orthogonality, showed to be perfectly suited for the separation of these apolar aglyca. However, several challenges were associated with the separation of the two polar xanthone glycosides 8 and 9. Regardless of which solvent gradient and additive (formic acid, acetic acid, diethylamine, triethylamine) were used, no adequate peak shape and resolution could be obtained. Temperature, flow rate, and pressure modifications did not improve the results either. Several publications have underlined the suitability of water as an additive for SFC separations of highly polar compounds.37,45−47 Water tends to enhance the solvation power of the mobile phase leading to increased solubility of hydrophilic compounds, thus enabling faster elution and improved peak shapes.48 This trend was also observed in the current study. The addition of 5.5% water to methanol improved peak shapes significantly and enabled the adequate resolution of the xanthone glycosides.
In the present work, an Acquity UPC2 BEH 2-EP column with 5.5% water in methanol as a modifier, operating at a temperature of 35 °C, an ABPR set to 1500 psi, and a flow rate of 1.1 mL/min, was identified as optimal for the rapid separation (within 12 min) of all nine reference compounds. Due to the various UV maxima of the compounds of interest, different wavelengths were selected for their detection: 232 nm was chosen for the xanthones gentisin (1) and isogentisin (2), as well as for swertiamarin (3), loganic acid (6), and amarogentin (7), 240 nm for sweroside (4), 257 nm for the xanthone glycosides (8, 9), and 268 nm for gentiopicroside (5).
Subsequently, all nine compounds could be assigned in the G. radix extracts (Figure 2) by comparison of retention times, UV spectra, and spiking experiments. Peak assignment and peak purity were further confirmed by coupling the UHPSFC system to a triple quadrupole mass spectrometer via an electrospray ionization interface. Due to the physical nature and compressibility of CO2 mobile phases, the hyphenation of SFC to MS is not as simple as in LC but requires the addition of an organic solvent, the so-called makeup solvent via an interface, located ahead of the MS detector.49,50 In the current investigation, methanol fortified with 0.5% formic acid was identified as the best-suited makeup solvent, allowing adequate ionization of all compounds in the negative ionization mode. The obtained MS spectra were highly consistent within each peak and showed no evidence of coeluting compounds.
Figure 2.
UHPSFC–DAD chromatograms of a G. radix extract (R-11) under optimized conditions: stationary phase: Acquity UPC2 BEH 2-EP (2.10 × 50.0 mm); mobile phase: CO2 (A) and MeOH with 5.5% H2O (B); gradient: 100% A at 0 min, 85% A at 0.2 min, 85% A at 5.5 min, 83% A at 5.7 min, 79% A at 6.2 min, and 73% A at 10.0 min, and held at this composition for 2 min; flow rate: 1.1 mL/min; temperature: 35 °C; ABPR: 1500 psi; and injection volume: 1 μL. Peak assignment is in accordance with Figure 1.
3.3. Validation of the UHPSFC–DAD Assay
To prove the suitability of the developed UHPSFC–DAD assay for quantitation purposes of compounds 1–9, validation was performed according to the ICH guidelines.43 As shown in Table 1, calibration curves were linear over the tested concentration range with correlation coefficients (R2) always higher than 0.9991. LOD estimates ranged from 0.2 to 1.6 μg/mL, whereas the LOQ estimates were found to vary between 0.7 and 4.9 μg/mL. These values are significantly higher, compared to those of the HPLC-UV assay of Aberham et al. (LOD ≤ 37 ng/mL and LOQ ≤ 112 ng/mL).28 Regarding this observation, one has to consider that only 1 μL was injected in our UHPSFC assay, while 10 μL was injected in the HPLC assay. Another possible explanation is the often-criticized lower sensitivity of SFC-UV compared to that of HPLC-UV. This was observed, e.g., also by Dispas et al., who reported a 10-time lower sensitivity of SFC compared to that of LC using the same detector.51
Table 1. Calibration Data of the G. lutea UHPSFC–DAD Assay for Compounds 1–9, Including Regression Equations, Correlation Coefficients (R2), and Linearity Range from LLOQ to ULOQ, LOD, and LOQ.
| compound | regression equation | R2 | linearity range (μg/mL) | LOD (μg/mL) | LOQ (μg/mL) |
|---|---|---|---|---|---|
| 1 | y = 3573x – 4569.2 | 0.9993 | 7.8–250 | 0.2 | 0.7 |
| 2 | y = 3316.6x – 12856 | 0.9992 | 3.7–570 | 0.5 | 1.6 |
| 3 | y = 1026.9x – 1903.2 | 0.9999 | 7.7–1030 | 1.0 | 3.2 |
| 4 | y = 1076.6x – 1307.8 | 0.9992 | 7.8–1050 | 0.7 | 2.1 |
| 5 | y = 845.29x – 1800.3 | 0.9994 | 8.3–1000 | 1.6 | 4.9 |
| 6 | y = 1044.2x + 2692.5 | 0.9993 | 9.1–1010 | 1.1 | 3.4 |
| 7 | y = 2002.7x – 1452.5 | 0.9995 | 7.8–1150 | 0.8 | 2.6 |
| 8 | y = 1856.1x + 3006.6 | 0.9991 | 6.6–105 | 0.6 | 1.9 |
| 9 | y = 2053.2x + 5348.7 | 0.9991 | 12.4–198 | 1.3 | 3.9 |
Precision was assayed by the preparation and analysis of G. radix extracts (R-1) on three consecutive days. During method validation, both intraday (RSD ≤ 5.1%) and interday (RSD ≤ 3.6%) results were satisfying and in a normal range for plant analysis (Table 2). For the assessment of accuracy and extraction efficiency, the powdered root material was spiked with known amounts of the reference compounds 1 and 3–8 at three different concentration levels before sample workup. Recovery rates for all investigated compounds were in the accepted range with values between 96.7 and 107.7% (see Table 3). Sample stability over the time range of the project was found to be within the limitations of the assay precision.
Table 2. G. lutea UHPSFC–DAD Assay Precision for Compounds 1–9a.
| compound | RSD (%) |
|||
|---|---|---|---|---|
| day 1 | day 2 | day 3 | days 1–3 | |
| 1 | 2.4 | 2.3 | 2.7 | 2.6 |
| 2 | 2.2 | 4.0 | 3.7 | 3.3 |
| 3 | 3.2 | 2.9 | 3.0 | 3.6 |
| 4 | 2.0 | 1.5 | 2.7 | 2.1 |
| 5 | 1.7 | 0.7 | 1.9 | 1.5 |
| 6 | 2.6 | 5.1 | 3.1 | 3.6 |
| 7 | 2.4 | 2.5 | 2.6 | 2.7 |
| 8 | 4.5 | 1.5 | 3.0 | 3.4 |
| 9 | 1.4 | 3.2 | 2.4 | 2.7 |
Intraday (n = 3 on each day) and interday (n = 9) precision.
Table 3. G. lutea UHPSFC–DAD Assay Accuracy for Compounds 1 and 3–8a.
| compound | low spike |
medium
spike |
high spike |
|||
|---|---|---|---|---|---|---|
| added (μg/mL) | recovery (%) | added (μg/mL) | recovery (%) | added (μg/mL) | recovery (%) | |
| 1 | 5.0 | 104.8 ± 1.6 | 10.0 | 99.1 ± 1.4 | 15.0 | 96.0 ± 1.6 |
| 3 | 10.0 | 104.6 ± 6.6 | 15.0 | 100.9 ± 2.4 | 20.0 | 97.0 ± 1.7 |
| 4 | 10.0 | 98.7 ± 1.7 | 15.0 | 95.9 ± 2.4 | 20.0 | 99.6 ± 1.8 |
| 5 | 15.0 | 96.7 ± 6.5 | 70.0 | 99.5 ± 4.8 | 150.0 | 96.8 ± 3.6 |
| 6 | 10.0 | 96.9 ± 3.5 | 40.0 | 104.4 ± 2.4 | 80.0 | 102.4 ± 4.9 |
| 7 | 5.0 | 105.8 ± 2.3 | 10.0 | 100.0 ± 6.0 | 15.0 | 107.7 ± 4.9 |
| 8 | 10.0 | 102.9 ± 2.7 | 30.0 | 93.4 ± 2.6 | 40.0 | 102.6 ± 7.1 |
Recovery values (n = 3) were expressed in the percentage of the amount added (mean ± relative standard).
3.4. Sample Analysis
The developed UHPSFC–DAD method was subsequently applied to the quantitative investigation of 13G. radix specimens, 7 liqueurs, and 3 clear spirits. Representative chromatograms of two G. radix extracts (R-11 and R-8) are shown in Figure 3A,B. The compiled quantitative results presented in Table 4 indicated that all nine reference compounds were detected in all investigated root specimens. The total content of bitter-tasting secoiridoids varied from 23.0 to 60.4 mg g–1 plant material, representing 2.3 to 6.0%, respectively. In all cases, gentiopicroside (5) was clearly the major compound with concentrations between 21.4 and 56.2 mg g–1 plant material. In 11 of the investigated 13 batches, the calculated gentiopicroside content reflected more than 90% of the total secoiridoid amount. All other secoiridoids (swertiamarin (3), sweroside (4), and amarogentin (7)) were present only in low concentrations. However, samples R-7 and R-8 were exceptions: the found sweroside (4) concentration of 13.1 and 10.8 mg g–1 plant material (representing 26.6 and 24.9% of the total secoiridoid content) was obviously higher compared to the other root samples, in some cases more than 10-fold. The concentration of amarogentin (7), the most bitter natural product known to date, was in all samples below 2.1 mg g–1 plant material. However, due to its high bitter value (58 million; in comparison: gentiopicroside: 12 000), it is anyway one of the value-determining ingredients.3,5,6
Figure 3.
UHPSFC–DAD chromatograms of two gentian root samples (A: R-11 and B: R-8) and two liqueur preparations (C: L-4 and D: L-7) under optimized conditions. Detection wavelength: 232 nm. Peak assignment is in accordance with Figure 1.
Table 4. Quantitative Results for Compounds 1–9 in Different G. radix Batches; All Values Are in mg g–1 Plant Material (with RSD in Parentheses; n = 3).
| 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | |
|---|---|---|---|---|---|---|---|---|---|
| R-1 | 0.47 (2.4) | 0.69 (4.3) | 1.47 (2.5) | 1.07 (2.5) | 27.15 (4.2) | 6.70 (2.0) | 0.26 (4.3) | 4.86 (4.5) | 3.37 (2.9) |
| R-2 | 0.92 (3.4) | 1.33 (2.1) | 1.19 (2.2) | 0.82 (1.1) | 28.63 (2.1) | 5.17 (1.2) | <LOQ | 4.39 (2.2) | 3.11 (1.5) |
| R-3 | 0.87 (2.1) | 0.84 (1.1) | 2.09 (1.9) | 0.44 (1.3) | 39.21 (0.8) | 5.12 (1.2) | 0.14 (5.6) | 5.37 (2.4) | 4.46 (1.7) |
| R-4 | 1.43 (2.2) | 2.49 (1.4) | 0.72 (1.6) | 0.37 (4.0) | 21.37 (2.0) | 1.11 (4.2) | 0.55 (2.0) | 1.58 (2.1) | 0.28 (4.9) |
| R-5 | 0.77 (1.6) | 1.11 (0.8) | 1.77 (4.2) | 0.76 (2.7) | 30.87 (2.1) | 4.50 (1.2) | <LOQ | 3.24 (7.8) | 2.18 (2.0) |
| R-6 | 0.65 (1.4) | 0.79 (1.2) | 0.97 (2.0) | 1.15 (3.6) | 24.45 (1.6) | 8.00 (1.2) | 0.38 (1.9) | 7.30 (1.4) | 5.83 (2.0) |
| R-7 | 0.49 (2.6) | 1.00 (1.7) | 1.49 (2.9) | 13.09 (0.8) | 32.57 (0.4) | 1.02 (3.7) | 2.11 (0.9) | 3.32 (1.7) | 4.64 (0.5) |
| R-8 | 0.15 (2.8) | 0.36 (1.4) | 1.27 (2.5) | 10.83 (2.0) | 30.94 (1.0) | 7.73 (1.7) | 0.47 (2.2) | 5.69 (2.7) | 2.06 (1.1) |
| R-9 | 0.86 (2.1) | 1.30 (3.3) | 1.06 (1.7) | 1.16 (1.7) | 27.91 (3.6) | 5.72 (3.6) | <LOQ | 3.83 (2.8) | 2.88 (3.1) |
| R-10 | 0.78 (2.6) | 0.88 (1.1) | 2.54 (2.2) | 1.54 (1.5) | 56.17 (2.1) | 5.69 (1.9) | 0.15 (2.9) | 2.76 (0.9) | 1.79 (1.7) |
| R-11 | 1.11 (3.8) | 1.01 (3.8) | 1.02 (3.4) | 0.59 (1.2) | 27.38 (2.0) | 6.48 (1.9) | 1.02 (3.8) | 4.93 (2.2) | 3.96 (2.2) |
| R-12 | 0.73 (1.6) | 0.77 (2.5) | 2.52 (2.1) | 1.77 (3.0) | 53.37 (1.7) | 5.97 (1.5) | <LOQ | 2.69 (1.3) | 1.70 (2.9) |
| R-13 | 1.07 (1.8) | 1.08 (1.1) | 1.03 (2.4) | 0.52 (3.2) | 27.82 (1.0) | 5.80 (1.3) | 1.02 (2.3) | 5.49 (1.1) | 4.32 (1.3) |
Regarding the xanthones, it was observed that the glycosides (8 and 9) predominated clearly over the aglyca (1 and 2). In addition, it was noted that gentioside (8) and its corresponding aglycon (2) were dominating over the respective isomers in almost all samples. All of these observations were in good agreement with the already published data.7,28,52
In the alpine region, two different kinds of liquid gentian root preparations, namely, liqueurs and clear spirits, are commercially available and traditionally used to stimulate appetite and increase digestion.27 To investigate whether significant amounts of the main bioactive compounds are contained, different liquid preparations, obtained from different suppliers in Austria and northern Italy, were analyzed. Gentian liqueurs are produced by simple maceration: the dried or fresh gentian roots are cut and steeped for several weeks in spirit. However, it must be considered that the preparation is not standardized between different suppliers: neither the amount of root material per bottle nor the exact extraction time is known. Due to these facts, strong variations between different preparations were already expected. However, as can be seen from the compiled results shown in Table 5, the variations were even larger than expected. The gentiopicroside concentration (5) varied from 2.22 mg/L (sample L-1) to 905.1 mg/L (sample L-3). Gentiopicroside was the main compound only in four liqueurs (L-3, L-5, L-6, L-7). In one liqueur (L-4), with a concentration of 85.3 mg/L, sweroside (4) was identified as the major compound, while in other two (L-1, L-2), loganic acid (6) dominated. These findings were quite unexpected, as in all investigated root samples (Table 4) gentiopicroside (5) was clearly dominating over all other quantified metabolites. As reported in the literature, the intense yellow color of the liqueurs is attributed to the contained xanthone derivatives.7 However, as displayed in representative chromatograms (Figure 3C,D), only the two aglyca gentisin (1) and isogentin (2) were detected. The respective glycosides 8 and 9, which occurred in quite high concentrations in the root batches (see Table 4 and Figure 3A,B), were not present in any investigated liqueur preparation.
Table 5. Quantitative Results for Compounds 1–9 in Different G. radix Liqueur Samples; All Values Are in mg L–1 Liqueur (with RSD in Parentheses; n = 3).
| 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | |
|---|---|---|---|---|---|---|---|---|---|
| L-1 | 3.55 (1.5) | 1.85 (3.8) | <LOQ | 9.30 (2.1) | 2.22 (4.1) | 35.54 (4.0) | 5.14 (3.9) | <LOQ | <LOQ |
| L-2 | 29.44 (2.6) | 41.88 (2.5) | 44.68 (1.3) | 13.92 (2.6) | 4.01 (2.3) | 181.78 (2.9) | 7.52 (2.0) | <LOQ | <LOQ |
| L-3 | 10.05 (2.2) | 14.62 (1.4) | 18.20 (2.1) | 57.52 (1.4) | 905.10 (1.5) | 68.06 (1.4) | 13.28 (1.6) | <LOQ | <LOQ |
| L-4 | 38.43 (1.8) | 16.98 (1.3) | 30.84 (1.5) | 85.31 (2.1) | 4.45 (4.3) | <LOQ | 49.64 (1.9) | <LOQ | <LOQ |
| L-5 | 65.29 (1.5) | 32.68 (1.8) | 9.75 (1.7) | 42.59 (1.0) | 66.06 (1.2) | 13.27 (2.4) | 27.02 (1.6) | <LOQ | <LOQ |
| L-6 | 13.46 (1.5) | 6.87 (2.7) | 13.97 (1.9) | 4.09 (3.6) | 56.53 (1.5) | 28.42 (2.4) | 3.55 (3.9) | <LOQ | <LOQ |
| L-7 | 34.73 (3.9) | 25.68 (4.9) | 40.21 (1.8) | 45.87 (1.8) | 661.31 (3.0) | 78.84 (2.0) | 18.97 (2.0) | <LOQ | <LOQ |
In contrast to gentian liqueurs, clear gentian spirits are obtained by distillation of the fermented root mash.27 Three different clear spirits were available for investigation. Measurable contents of the chosen reference compounds (1–9) were not observed in any of these. Due to the manufacturing process and the nonvolatile character of the investigated compounds (see Figure 1 for structures), these results were unsurprising.
Taken together, the results are underlining the excellent suitability of the UHPSFC assay for the quality control of gentian, combining features of rapid and highly efficient separation performance with advantages of low operating costs and eco-friendliness. The fact that the assay enables the simultaneous determination of polar secondary metabolites with divergent characteristics, including bitter-tasting secoiridoids, as well as iridoids, xanthones, and xanthone glycosides, highlights once more the broad and still often underestimated potential of SFC for natural product analysis. With a total analysis time of 12 min, thus a reduction to one-third, the method represents a significant improvement and advantage compared to the conventional HPLC assay.28 We could show that beside the quality control of gentian root batches, the method is additionally a useful and reliable tool for the investigation of commercially available liqueurs and spirits. However, as shown by the presented results, the content of the pharmacologically relevant secondary metabolites in liquid preparations is varying strongly. To explain the reasons for these variations, further investigations with a bigger sample set, as well as with profound knowledge of the origin of the root material used for production and the exact preparation conditions, are needed. Generally, the rich secondary metabolite profile of the root materials of pharmacopeia quality cannot be found in the fermentation or maceration-based liquids. Hence, the health benefits of liqueur/spirit consumption cannot be expected to meet the benefits associated with the use of Ph. Eur. quality material.
Glossary
Abbreviations
- ABPR
automated back-pressure regulator
- CO2
carbon dioxide
- DAD
diode array detector
- LOD
limit of detection
- LOQ
limit of quantitation
- MeOH
methanol
- UHPSFC
ultra-high performance supercritical fluid chromatography
Supporting Information Available
The Supporting Information is available free of charge at https://pubs.acs.org/doi/10.1021/acs.jafc.2c01584.
NMR spectroscopic data and a detailed description of the isolation procedure of the xanthones gentisin 1 and isogentisin 2 and the xanthone glycosides gentioside 8 (= isogentisin-3-O-primveroside) and gentioside-isomer 9 (= gentisin-7-O-primveroside) (PDF)
This research was supported by Bionorica Research GmbH.
The authors declare no competing financial interest.
This paper was published ASAP on June 13, 2022, with a small part of the Sweroside structure missing. The corrected version was reposted on June 13, 2022.
Supplementary Material
References
- Kelber O.; Bauer R.; Kubelka W. Phytotherapy in Functional Gastrointestinal Disorders. Dig. Dis. 2018, 35, 36–42. 10.1159/000485489. [DOI] [PubMed] [Google Scholar]
- Principles and Practice of Phytotherapy, 2nd ed.; Bone K.; Mills S., Eds.; Churchill Livingstone: Saint Louis, 2013. [Google Scholar]
- Blaschek W.; Ebel S.; Hackenthal E.; Holzgrabe U.; Keller K.; Reichling J.; Schulz V.. Hagers Enzyklopädie der Arzneistoffe und Drogen, 6th ed.; Wissenschaftliche Verlagsgesellschaft: Stuttgart, 2007. [Google Scholar]
- Enzianwurzel - Gentianae Radix (No. 9.0/ 0392). In Europäisches Arzneibuch; Deutscher Apotheker Verlag: Stuttgart, 2017; pp 2033–2035. [Google Scholar]
- Blaschek W. W.Wichtl - Teedrogen Und Phytopharmaka: Ein Handbuch Für Die Praxis, 6th ed.; Wissenschaftliche Verlagsagentur: Stuttgart, 2016. [Google Scholar]
- Seitz R.; Lange D.; Franz C. Gelber Enzian. Zeitschrift für Phytotherapie 2005, 26, 143–151. 10.1055/s-2005-872307. [DOI] [Google Scholar]
- Committee on Herbal Medicinal Products (HMPC) Assessment Report on Gentiana Lutea L., Radix, EMA/HMPC/607863/2017; European Medicines Agency: London, 2018. [Google Scholar]
- European Scientific Cooperative on Phytotherapy . Gentianae Radix. In ESCOP Monographs, 2014; pp 229–248. [Google Scholar]
- Kusar A.; Zupancic A.; Sentjurc M.; Baricevic D. Free Radical Scavenging Activities of Yellow Gentian (Gentiana Lutea L.) Measured by Electron Spin Resonance. Hum. Exp. Toxicol. 2006, 25, 599–604. 10.1177/096032706072467. [DOI] [PubMed] [Google Scholar]
- Amin A. Ketoconazole-Induced Testicular Damage in Rats Reduced by Gentiana Extract. Exp. Toxicol. Pathol. 2008, 59, 377–384. 10.1016/j.etp.2007.10.008. [DOI] [PubMed] [Google Scholar]
- Azman N. A. M.; Segovia F.; Martínez-Farré X.; Gil E.; Almajano M. P. Screening of Antioxidant Activity of Gentian Lutea Root and Its Application in Oil-in-Water Emulsions. Antioxidants 2014, 3, 455–471. 10.3390/antiox3020455. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Šavikin K.; Menković N.; Zdunić G.; Stević T.; Radanović D.; Janković T. Antimicrobial Activity of Gentiana Lutea L. Extracts. Z. Naturforschung C J. Biosci. 2009, 64, 339–342. 10.1515/znc-2009-5-606. [DOI] [PubMed] [Google Scholar]
- Kumarasamy Y.; Nahar L.; Sarker S. D. Bioactivity of Gentiopicroside from the Aerial Parts of Centaurium Erythraea. Fitoterapia 2003, 74, 151–154. 10.1016/S0367-326X(02)00319-2. [DOI] [PubMed] [Google Scholar]
- Mahady G. B.; Pendland S. L.; Stoia A.; Hamill F. A.; Fabricant D.; Dietz B. M.; Chadwick L. R. In Vitro Susceptibility of Helicobacter Pylori to Botanical Extracts Used Traditionally for the Treatment of Gastrointestinal Disorders. Phytother. Res. 2005, 19, 988–991. 10.1002/ptr.1776. [DOI] [PubMed] [Google Scholar]
- Van Der Sluis W. G.; Van Der Nat J. M.; Labadie R. P. Thin-Layer Chromatographic Bioassay of Iridoid and Secoiridoid Glucosides with a Fungitoxic Aglucone Moiety Using β-Glucosidase and the Fungus Penicillium Expansum as a Test Organism. J. Chromatogr. A 1983, 259, 522–526. 10.1016/S0021-9673(01)88046-8. [DOI] [PubMed] [Google Scholar]
- Kondo Y.; Takano F.; Hojo H. Suppression of Chemically and Immunologically Induced Hepatic Injuries by Gentiopicroside in Mice. Planta Med. 1994, 60, 414–416. 10.1055/s-2006-959521. [DOI] [PubMed] [Google Scholar]
- Kesavan R.; Potunuru U. R.; Nastasijević B.; T A.; Joksić G.; Dixit M. Inhibition of Vascular Smooth Muscle Cell Proliferation by Gentiana Lutea Root Extracts. PLoS One 2013, 8, e61393 10.1371/journal.pone.0061393. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Öztürk N.; Korkmaz S.; Oztürk Y.; Başer K. H. C. Effects of Gentiopicroside, Sweroside and Swertiamarine, Secoiridoids from Gentian (Gentiana Lutea Ssp. Symphyandra), on Cultured Chicken Embryonic Fibroblasts. Planta Med. 2006, 72, 289–294. 10.1055/s-2005-916198. [DOI] [PubMed] [Google Scholar]
- Zimmermann W.; Gaisbauer G.; Gaisbauer M. Wirkung von Bitterstoff-Drogen Auf Das Darmassoziierte Immunsystem. Z. Phytother. 1986, 7, 56–59. [Google Scholar]
- Chibanguza G.; März R.; Sterner W. Wirksamkeit Und Toxizität Eines Pflanzlichen Sekretolytikums Und Seiner Einzeldrogen. Arzneimittelforsch 1984, 34, 32–36. [PubMed] [Google Scholar]
- Wölfle U.; Haarhaus B.; Seiwerth J.; Cawelius A.; Schwabe K.; Quirin K.-W.; Schempp C. M. The Herbal Bitter Drug Gentiana Lutea Modulates Lipid Synthesis in Human Keratinocytes In Vitro and In Vivo. Int. J. Mol. Sci. 2017, 18, 1814. 10.3390/ijms18081814. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Kesavan R.; Chandel S.; Upadhyay S.; Bendre R.; Ganugula R.; Potunuru U. R.; Giri H.; Sahu G.; Kumar P. U.; Reddy G. B.; Joksic G.; Bera A. K.; Dixit M. Gentiana Lutea Exerts Anti-Atherosclerotic Effects by Preventing Endothelial Inflammation and Smooth Muscle Cell Migration. Nutr., Metab. Cardiovasc. Dis. 2016, 26, 293–301. 10.1016/j.numecd.2015.12.016. [DOI] [PubMed] [Google Scholar]
- Haraguchi H.; Tanaka Y.; Kabbash A.; Fujioka T.; Ishizu T.; Yagi A. Monoamine Oxidase Inhibitors from Gentiana Lutea. Phytochemistry 2004, 65, 2255–2260. 10.1016/j.phytochem.2004.06.025. [DOI] [PubMed] [Google Scholar]
- Waltenberger B.; Liu R.; Atanasov A. G.; Schwaiger S.; Heiss E. H.; Dirsch V. M.; Stuppner H. Nonprenylated Xanthones from Gentiana Lutea, Frasera Caroliniensis, and Centaurium Erythraea as Novel Inhibitors of Vascular Smooth Muscle Cell Proliferation. Molecules 2015, 20, 20381–20390. 10.3390/molecules201119703. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Schmieder A.; Schwaiger S.; Csordas A.; Backovic A.; Messner B.; Wick G.; Stuppner H.; Bernhard D. Isogentisin--a Novel Compound for the Prevention of Smoking-Caused Endothelial Injury. Atherosclerosis 2007, 194, 317–325. 10.1016/j.atherosclerosis.2006.10.019. [DOI] [PubMed] [Google Scholar]
- Bundesministerium Landwirtschaft, Regionen und Tourismus. Enzian - Traditionell hergestellter Brand aus den Wurzeln des Gelben Enzians (Gentiana lutea) und Punktierten Enzians (Gentiana punctata) in Tirol. https://www.bmnt.gv.at/land/lebensmittel/trad-lebensmittel/getraenke/enzian.html (accessed Nov 24, 2019).
- Aberham A.; Schwaiger S.; Stuppner H.; Ganzera M. Quantitative Analysis of Iridoids, Secoiridoids, Xanthones and Xanthone Glycosides in Gentiana Lutea L. Roots by RP-HPLC and LC-MS. J. Pharm. Biomed. Anal. 2007, 45, 437–442. 10.1016/j.jpba.2007.07.001. [DOI] [PubMed] [Google Scholar]
- Aberham A.; Pieri V.; Croom E. M.; Ellmerer E.; Stuppner H. Analysis of Iridoids, Secoiridoids and Xanthones in Centaurium Erythraea, Frasera Caroliniensis and Gentiana Lutea Using LC-MS and RP-HPLC. J. Pharm. Biomed. Anal. 2011, 54, 517–525. 10.1016/j.jpba.2010.09.030. [DOI] [PubMed] [Google Scholar]
- Carnat A.; Fraisse D.; Carnat A.-P.; Felgines C.; Chaud D.; Lamaison J.-L. Influence of Drying Mode on Iridoid Bitter Constituent Levels in Gentian Root. J. Sci. Food Agric. 2005, 85, 598–602. 10.1002/jsfa.2011. [DOI] [Google Scholar]
- Szucs Z.; Dános B.; Nyiredy Sz. Comparative Analysis of the Underground Parts of Gentiana Species by HPLC with Diode-Array and Mass Spectrometric Detection. Chromatographia 2002, 56, S19–S23. 10.1007/BF02494108. [DOI] [Google Scholar]
- Xu Y.; Li Y.; Maffucci K. G.; Huang L.; Zeng R. Analytical Methods of Phytochemicals from the Genus Gentiana. Molecules 2017, 22, 2080. 10.3390/molecules22122080. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Gibitz Eisath N.; Sturm S.; Stuppner H. Supercritical Fluid Chromatography in Natural Product Analysis - An Update. Planta Med. 2018, 84, 361–371. 10.1055/s-0037-1599461. [DOI] [PubMed] [Google Scholar]
- Ganzera M.; Zwerger M. Analysis of Natural Products by SFC – Applications from 2015 to 2021. TrAC, Trends Anal. Chem. 2021, 145, 116463 10.1016/j.trac.2021.116463. [DOI] [Google Scholar]
- He P.-x.; Zhang Y.; Zhou Y.; Li G.; Zhang J.; Feng X. Supercritical Fluid Chromatography–a Technical Overview and Its Applications in Medicinal Plant Analysis: An Update Covering 2012–2018. Analyst 2019, 144, 5324–5352. 10.1039/C9AN00826H. [DOI] [PubMed] [Google Scholar]
- West C. Current Trends in Supercritical Fluid Chromatography. Anal. Bioanal. Chem. 2018, 410, 6441–6457. 10.1007/s00216-018-1267-4. [DOI] [PubMed] [Google Scholar]
- Huang Y.; Zhang T.; Zhou H.; Feng Y.; Fan C.; Chen W.; Crommen J.; Jiang Z. Fast Separation of Triterpenoid Saponins Using Supercritical Fluid Chromatography Coupled with Single Quadrupole Mass Spectrometry. J. Pharm. Biomed. Anal. 2016, 121, 22–29. 10.1016/j.jpba.2015.12.056. [DOI] [PubMed] [Google Scholar]
- Huang Y.; Zhang T.; Zhao Y.; Zhou H.; Tang G.; Fillet M.; Crommen J.; Jiang Z. Simultaneous Analysis of Nucleobases, Nucleosides and Ginsenosides in Ginseng Extracts Using Supercritical Fluid Chromatography Coupled with Single Quadrupole Mass Spectrometry. J. Pharm. Biomed. Anal. 2017, 144, 213–219. 10.1016/j.jpba.2017.03.059. [DOI] [PubMed] [Google Scholar]
- Zhu L.-L.; Zhao Y.; Xu Y.-W.; Sun Q.-L.; Sun X.-G.; Kang L.-P.; Yan R.-Y.; Zhang J.; Liu C.; Ma B.-P. Comparison of Ultra-High Performance Supercritical Fluid Chromatography and Ultra-High Performance Liquid Chromatography for the Separation of Spirostanol Saponins. J. Pharm. Biomed. Anal. 2016, 120, 72–78. 10.1016/j.jpba.2015.12.002. [DOI] [PubMed] [Google Scholar]
- Desfontaine V.; Losacco G. L.; Gagnebin Y.; Pezzatti J.; Farrell W. P.; González-Ruiz V.; Rudaz S.; Veuthey J.-L.; Guillarme D. Applicability of Supercritical Fluid Chromatography - Mass Spectrometry to Metabolomics. I - Optimization of Separation Conditions for the Simultaneous Analysis of Hydrophilic and Lipophilic Substances. J. Chromatogr. A 2018, 1562, 96–107. 10.1016/j.chroma.2018.05.055. [DOI] [PubMed] [Google Scholar]
- Gibitz-Eisath N.; Eichberger M.; Gruber R.; Seger C.; Sturm S.; Stuppner H. Towards Eco-Friendly Secondary Plant Metabolite Quantitation: Ultra High Performance Supercritical Fluid Chromatography Applied to Common Vervain (Verbena Officinalis L.). J. Sep. Sci. 2020, 43, 829–838. 10.1002/jssc.201900854. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Hayashi T.; Yamagishi T. Two Xanthone Glycosides from Gentiana Lutea. Phytochemistry 1988, 27, 3696–3699. 10.1016/0031-9422(88)80805-7. [DOI] [Google Scholar]
- International Conference on Harmonization (ICH). ICH Harmonized Tripartite Guideline: Validation of Analytical Procedures: Text and Methodology Q2 (R1). 1994.
- Fairchild J.Influence of Sample Solvent Composition in SFC Separations, 2013; Vol. 31.
- Sen A.; Knappy C.; Lewis M. R.; Plumb R. S.; Wilson I. D.; Nicholson J. K.; Smith N. W. Analysis of Polar Urinary Metabolites for Metabolic Phenotyping Using Supercritical Fluid Chromatography and Mass Spectrometry. J. Chromatogr. A 2016, 1449, 141–155. 10.1016/j.chroma.2016.04.040. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Ashraf-Khorassani M.; Taylor L. T. Subcritical Fluid Chromatography of Water Soluble Nucleobases on Various Polar Stationary Phases Facilitated with Alcohol-Modified CO2 and Water as the Polar Additive. J. Sep. Sci. 2010, 33, 1682–1691. 10.1002/jssc.201000047. [DOI] [PubMed] [Google Scholar]
- Liu J.; Regalado E. L.; Mergelsberg I.; Welch C. J. Extending the Range of Supercritical Fluid Chromatography by Use of Water-Rich Modifiers. Org. Biomol. Chem. 2013, 11, 4925–4929. 10.1039/c3ob41121d. [DOI] [PubMed] [Google Scholar]
- Taylor L. T. Packed Column Supercritical Fluid Chromatography of Hydrophilic Analytes via Water-Rich Modifiers. J. Chromatogr. A 2012, 1250, 196–204. 10.1016/j.chroma.2012.02.037. [DOI] [PubMed] [Google Scholar]
- Desfontaine V.; Veuthey J.-L.; Guillarme D.. Chapter 8 - Hyphenated Detectors: Mass Spectrometry. In Supercritical Fluid Chromatography Poole C. F., Ed.; Elsevier: Amsterdam, 2017; pp 213–238 10.1016/B978-0-12-809207-1.00015-X. [DOI] [Google Scholar]
- Pinkston J. D. Advantages and Drawbacks of Popular Supercritical Fluid Chromatography / Mass Spectrometry Interfacing Approaches—A User’s Perspective. Eur. J. Mass Spectrom. 2005, 11, 189–197. 10.1255/ejms.731. [DOI] [PubMed] [Google Scholar]
- Dispas A.; Lebrun P.; Ziemons E.; Marini R.; Rozet E.; Hubert P. Evaluation of the Quantitative Performances of Supercritical Fluid Chromatography: From Method Development to Validation. J. Chromatogr. A 2014, 1353, 78–88. 10.1016/j.chroma.2014.01.046. [DOI] [PubMed] [Google Scholar]
- Mustafa A. M.; Caprioli G.; Ricciutelli M.; Maggi F.; Marín R.; Vittori S.; Sagratini G. Comparative HPLC/ESI-MS and HPLC/DAD Study of Different Populations of Cultivated, Wild and Commercial Gentiana Lutea L. Food Chem. 2015, 174, 426–433. 10.1016/j.foodchem.2014.11.089. [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.



